# | ||||
---|---|---|---|---|
1 | REGENHEART Clinical development and proof of principle testing of new regenerative VEGF-D therapy for cost-effective treatment of refractory anginaA phase II randomized, double-blinded, placebo-controlled study | 2017 | 5˙934˙088.00 | 5˙934˙086.00 |
The Institution POHJOIS-SAVON SAIRAANHOITOPIIRIN KUNTAYHTYMA has been involved also in the following Horizon 2020 projects.